Preventable harm because of outpatient medication errors among children with leukemia and lymphoma: A multisite longitudinal assessment
Authors:
- Chris I. WongCWChris I. Wong
- Kathryn VannattaKVKathryn Vannatta
- Jordan Gilleland MarchakJMJordan Gilleland Marchak
- Isabelle M. RodgersIRIsabelle M. Rodgers
- Christopher E. DandoyCDChristopher E. Dandoy
- Amy L. BillettABAmy L. Billett
- Tamara P. MillerTMTamara P. Miller
- Nancy M. DaraisehNDNancy M. Daraiseh
- Shanshan LiuSLShanshan Liu
Abstract
Background: There is little longitudinal information about the type and frequency of harm resulting from medication errors among outpatient children with cancer. We aimed to characterize rates and types of medication errors and harm to outpatient children with leukemia and lymphoma over 7 months of treatment.Methods: We recruited children taking medications at home for leukemia or lymphoma from three pediatric cancer centers. Errors were identified by chart review, in‐home medication review, observation of administration, and interviews. Physician reviewers confirmed error (Fleiss' κ = 0.95), harm (Fleiss' κ = 0.82), and suggested interventions. Generalized linear mixed models with random effects were used to account for clustering by site.Results: Among 131 children taking 1669 medications with 367 home visits, 408 errors were identified, including 242 with potential for harm and 39 with harm (1.0 harm per 1000 patient‐days [95% CI, 0.1–9.8]). Ten percent of children were injured by errors and 42% had errors with potential for harm. Twenty‐six percent of caregivers reported that miscommunication led to missed doses or overdoses at home. Children on >13 medications had significantly more serious medication errors than those on fewer medications (77% vs 61%; p = .05). Physician reviewers judged that improved communication among caregivers and between caregivers and clinicians may have prevented the most harm (66%).Conclusions: In this longitudinal study, 10% children with leukemia or lymphoma experienced adverse drug events because of outpatient medication errors. Improvements addressing communication with and among caregivers should be codeveloped with families and based on human‐factors engineering.Plain Language Summary: In this longitudinal study, medication errors in the clinic, pharmacy, or at home among children with leukemia or lymphoma over a 7‐month period were common, and 10% suffered harm because of errors. Children on >13 medications had significantly more serious medication errors than those on fewer medications (77% vs 61%; p = .05). Physician reviewers judged that improved communication among caregivers and between caregivers and clinicians may have prevented the most harm (66%). Improvements addressing communication with and among caregivers should be codeveloped with families and based on human‐factors engineering.Keywords
Funding Information
- Agency for Healthcare Research and Quality (R01 HS024390)
This publication has 27 references indexed in Scilit:
- Multisite Parent-Centered Risk Assessment to Reduce Pediatric Oral Chemotherapy ErrorsJournal of Oncology Practice, 2013
- Nonadherence to Oral Mercaptopurine and Risk of Relapse in Hispanic and Non-Hispanic White Children With Acute Lymphoblastic Leukemia: A Report From the Children's Oncology GroupJournal of Clinical Oncology, 2012
- Medication errors in the homes of children with chronic conditionsArchives of Disease in Childhood, 2011
- Medication errors involving oral chemotherapyCancer, 2010
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- Medication Errors Among Adults and Children With Cancer in the Outpatient SettingJournal of Clinical Oncology, 2009
- A Surgical Safety Checklist to Reduce Morbidity and Mortality in a Global PopulationNew England Journal of Medicine, 2009
- Work system design for patient safety: the SEIPS modelQuality and Safety in Health Care, 2006
- Potential Medication Dosing Errors in Outpatient PediatricsThe Journal of Pediatrics, 2005
- Medication safety in the ambulatory chemotherapy settingCancer, 2005